Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MBRX

Moleculin Biotech Inc

Jun 11 • 04:00PM ET

2.70

+0.20 8.00 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BLRX CYCN ERNA GDTC GNTA GTBP ICU INTS RKTO TOVX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.04	Insider Own	0.83%	Shs Outstand	5.34M	Perf Week	7.57%
Market Cap	14.41M	Forward P/E	-	EPS next Y	-3.84	Insider Trans	0.00%	Shs Float	5.29M	Perf Month	15.38%
Enterprise Value	4.42M	PEG	-	EPS next Q	-1.54	Inst Own	3.21%	Short Float	15.67%	Perf Quarter	31.71%
Income	-32.20M	P/S	-	EPS this Y	82.01%	Inst Trans	1.13%	Short Ratio	4.76	Perf Half Y	-59.28%
Sales	0.00M	P/B	0.95	EPS next Y	24.84%	ROA	-136.70%	Short Interest	0.83M	Perf YTD	-18.43%
Book/sh	2.85	P/C	1.40	EPS next 5Y	49.99%	ROE	-398.45%	52W High	24.00 -88.75%	Perf Year	-84.34%
Cash/sh	1.93	P/FCF	-	EPS past 3/5Y	57.89% 46.71%	ROIC	-197.37%	52W Low	1.79 50.84%	Perf 3Y	-98.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.26% 9.15%	Perf 5Y	-99.81%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.65%	Oper. Margin	-	ATR (14)	0.20	Perf 10Y	-99.98%
Dividend Ex-Date	-	Quick Ratio	1.38	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	59.48	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.38	EPS Q/Q	79.43%	SMA20	9.91%	Beta	1.75	Target Price	21.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	9.61%	Rel Volume	1.12	Prev Close	2.50
Employees	17	LT Debt/Eq	0.01	Earnings	May 15 BMO	SMA200	-54.41%	Avg Volume	174.33K	Price	2.70
IPO	Jun 02, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	-51.72% -	Trades		Volume	194,391	Change	8.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)